For the year ending 2025-12-28, JNJ made $94,193M in revenue. $26,804M in net income. Net profit margin of 28.46%.
| Income Statement | 2025-12-28 | 2024-12-29 | 2023-12-31 | 2023-01-01 |
|---|---|---|---|---|
| Sales to customers | 94,193 | 88,821 | 85,159 | 94,943 |
| Cost of products sold | 30,256 | 27,471 | 26,553 | 31,089 |
| Gross profit | 63,937 | 61,350 | 58,606 | 63,854 |
| Selling, marketing and administrative expenses | 23,676 | 22,869 | 21,512 | 24,765 |
| Research and development expense | 14,665 | 17,232 | 15,085 | 14,603 |
| In-process research and development (note 5) | - | - | - | 783 |
| In-process research and development impairments | 81 | 211 | 313 | - |
| Interest income | 1,056 | 1,332 | 1,261 | 490 |
| Interest expense, net of portion capitalized | 971 | 755 | 772 | 276 |
| Other (income) expense, net | 7,209 | -4,694 | -6,634 | -1,871 |
| Restructuring | 228 | 234 | 489 | 321 |
| Earnings before provision for taxes on income | 32,581 | 16,687 | 15,062 | 21,725 |
| Effective rate | 5,777 | 2,621 | 1,736 | 3,784 |
| Net earnings from continuing operations | 26,804 | 14,066 | 13,326 | - |
| Net earnings from discontinued operations | 0 | 0 | 21,827 | - |
| Net earnings | 26,804 | 14,066 | 35,153 | 17,941 |
| Basic (in dollars per share) | 11.13 | 5.84 | 13.88 | 6.83 |
| Basic (in shares) | 2,407,400,000 | 2,407,300,000 | 2,533,500,000 | 2,625,200,000 |
| Diluted (in dollars per share) | 11.03 | 5.79 | 13.72 | 6.73 |
| Diluted (in shares) | 2,429,400,000 | 2,429,400,000 | 2,560,400,000 | 2,663,900,000 |
JOHNSON & JOHNSON (JNJ)
JOHNSON & JOHNSON (JNJ)